Newly discovered gene may protect against heart disease

February 14, 2018 by Amy Albin, University of California, Los Angeles
Mouse blood vessel with plaque accumulation. Credit: Sallam Lab

Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol from blood vessels.

Published in the journal Nature Medicine, the UCLA-led study in mice found that MeXis controls the expression of a protein that pumps cholesterol out of in the artery wall.

MeXis is an example of a "selfish" gene, one that is presumed to have no function because it does not make a protein product. However, recent studies have suggested that these so-called "unhelpful" can actually perform important biological functions without making proteins and instead producing a special class of molecules called long non-coding RNAs, or lncRNAs.

"What this study tells us is that lncRNAs are important for the inner workings of cells involved in the development of heart disease," said Dr. Peter Tontonoz, senior author of the study. He is also the Frances and Albert Piansky Professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA. "Considering many genes like MeXis have completely unknown functions, our study suggests that further exploring how other long non-coding RNAs act will lead to exciting insights into both normal physiology and disease."

In the study, researchers found that mice lacking MeXis had almost twice as many blockages in their compared to mice with normal MeXis levels. In addition, boosting MeXis levels made cells more effective at removing excess cholesterol.

UCLA researchers Tamer Sallam, left, and Peter Tontonoz expect that further exploration will lead to new insights into normal physiology as well as disease. Credit: UCLA Health

In the next phase of the study, researchers will further explore how MeXis affects the function of cells in the and will test various approaches to altering MeXis activity. The researchers are interested in finding out if MeXis could be targeted for therapy of cardiovascular disease.

"The idea that lncRNAs are directly involved in very common ailments such as plaque buildup within arteries offers new ways of thinking about how to treat and diagnose ," said Dr. Tamer Sallam, the study's lead author. Sallam is an assistant professor in the department of medicine and co-director of UCLA Center for Cholesterol Management. "There is likely a good reason why genes that make RNAs rather than proteins exist. A key question for us moving forward is how they may be involved in health and ."

Explore further: Study could explain link between high-cholesterol diet and colon cancer

More information: Tamer Sallam et al, Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA, Nature Medicine (2018). DOI: 10.1038/nm.4479

Related Stories

Study could explain link between high-cholesterol diet and colon cancer

January 25, 2018
New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.

Gene therapy using 'junk DNA' could lower risk for heart disease

August 28, 2017
Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce plaque in mice with a disorder called familial hypercholesterolemia. ...

Finding long strands of RNA in skin development and disease

December 6, 2017
Researchers from Case Western Reserve University School of Medicine have discovered how unusually long pieces of RNA work in skin cells. The RNA pieces, called "long non-coding RNAs" or "lncRNAs," help skin cells modulate ...

Back to basics for heart health

February 2, 2018
As heart month kicks off, doctors at Baylor College of Medicine say the first step to taking control of your health and preventing cardiovascular disease is understanding the basics and what they represent for your heart.

Navigating the genome to cure deafness

November 2, 2017
A new Tel Aviv University study solves a critical piece of the puzzle of human deafness by identifying the first group of long non-coding RNAs (lncRNAs) in the auditory system.

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Recommended for you

Physical activity necessary to maintain heart-healthy lifestyle

September 24, 2018
Exercise and physical activity are of vast global importance to prevent and control the increasing problem of heart disease and stroke, according to a review paper published today in the Journal of the American College of ...

Height may be risk factor for varicose veins, study finds

September 24, 2018
The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues ...

Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death

September 24, 2018
In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a high number experienced severe and ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Can a common heart condition cause sudden death?

September 20, 2018
About one person out of 500 has a heart condition known as hypertrophic cardiomyopathy (HCM). This condition causes thickening of the heart muscle and results in defects in the heart's electrical system. Under conditions ...

New drugs could reduce risk of heart disease when added to statins

September 20, 2018
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are in various stages of development, could also reduce blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.